Catalyst Wire Dossier Catalyst Wire Dossier

T-614

t-614 · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-614, covering 2015-06-19 to 2015-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 3]

See pricing